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Abstract
Objective: To identify factors associated with develop-
ment of albuminuria in diabetic patients.
Methods: A hospital based caseecontrol study. Fifty
diabetic nephropathy patients were compared with 100
diabetic patients without nephropathy. Data were
collected using an interview questionnaire. Frequencies,
percentages and mean were calculated. Chi-square test,
T-test and Univariate logistic regression analysis were
used. P < 0.05 was considered significant.
Results: An Univariate logistic regression analysis has
shown significant associated factors including old age
(OR ¼ 8.1) (95%CI ¼ 2.2e30.1), sex (male) (OR ¼ 2.4)
(95%CI ¼ 1.18e4.99), the duration of diabetes mellitus
above 10 years OR were 4.23 (95%C ¼ 1.6e15.4), asso-
ciated mild, moderate, and severe hypertension ORs were
5.2 (95%CI ¼ 2.3e11.7), 5.1 (95%CI ¼ 1.5e16.93) and
15.2 (95%CI ¼ 1.4e158.1), respectively, cardiac
disease (OR ¼ 3.77) (95%CI ¼ 1.6e8.7), using
Angiotensin-Converting Enzyme Inhibitors (ACEIs) and
Angiotensin II Receptor Blockers (ARBs) (OR ¼ 8.1)y. This is an open access article under the CC BY-NC-ND license
.1016/j.jtumed.2014.09.004
D.G. Al-shehri et al. 251(95% CI ¼ 3.61e18.2), low triglyceride level (OR ¼ 0.38)
(95%CI ¼ 0.10e0.81).
Conclusion: Six factors showed a significant positive
relationship to the progression of albuminuria in diabetic
patients. Older age and males were found to be predictors
of high albuminuria. Also, cardiac disease, poor hyper-
tension control, the use of ACEIs or ARBs were found to
be predictors of higher albuminuria. Low triglyceride
levels were significantly associated with low albuminuria.
Higher levels of HbA1c showed less albuminuria while
body mass index, smoking and retinopathy showed no
association to the albuminuria.
Keywords: Albuminuria; Diabetes mellitus; Factors;
Nephropathy
 2014 The Authors.
Production and hosting by Elsevier Ltd on behalf of Taibah
University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Diabetes mellitus (DM) is a worldwide health problem
that affects many people and is accompanied by severe
complications that negatively affect these individuals.1 In the
Kingdom of Saudi Arabia, DM appears as a major public
health issue at levels parallel to the worldwide diabetes
pandemic.2 The prevalence of DM is rapidly increasing all
over the world.1 Its prevalence among adults in the
Kingdom of Saudi Arabia is at 23.7%, a value that is
expected to increase in the future.2
Diabetic nephropathy (DN) can be a kidney disease or
kidney damage resulting from diabetes without unknown
causes. Uncontrolled high blood sugar levels are believed to
be one of the causes of kidney damage.3 DN, also called
KimmelstieleWilson disease, is characterized by a
progressive rise in urine albumin excretion, increased blood
pressure, a relentless decline in glomerular filtration, and
ultimately end-stage kidney failure.4 Diabetes is the fifth
leading cause of death according to the Center of Disease
Control while kidney disease is ranked ninth.5 A
downgrade of kidney function over time has been the nexus
between initial glomerular filtration rate, initial urinary
albumin excretion rate (UAE), hyperglycemia, and age.6
Increased urinary protein excretion is the earliest clinical
manifestation of diabetic nephropathy.4 However, tight
control of blood glucose levels has been shown to reduce
the development of nephropathy but did not reverse
nephropathy once protein (albumin) began passing into the
urine.3,7 In many countries, there is a marked and
remarkable increase in the incidence of patients with
diabetic nephropathy that have reached end-stage kidney
disease over recent decades.8,9
Persistent microalbuminuria (urinary albumin excretion
rate between 30 and 300 mg/24 h) may be indicative of early
diabetic nephropathy. This is also an established risk factorfor the development of macroalbuminuria (urinary albumin
excretion rate greater than 300 mg/24 h).10
Since 1990, the incidence of end stage kidney disease has
doubled in theU.S. and diabetic nephropathy is now the single
most common cause of end-stage kidney failure worldwide.11Materials and Methods
This was a hospital-based case control study. The subjects
were 50 diabetic nephropathy patients who were randomly
selected from the nephrology unit of King Fahad Hospital.
We selected every other patient having all inclusion criteria.
These patients were compared with 100 diabetic patients who
were without nephropathy and chosen randomly from the
diabetic center of the same hospital. These groups were used
to determine the risk factors of developing nephropathy
among diabetic patients.
Patients with other kidney diseases, especially stone and
prostate diseases were excluded from this study. Patients
with systemic diseases, like heart failure or liver disease, were
excluded as well. Additionally, patients who were morbidly
obese or of an extreme age (younger than 20 or older than 70)
were excluded from the study.
Diagnosis of diabetic nephropathy depended on the
detection of albuminuria by using microassays and dip-stick.
Informed consent was obtained verbally from each pa-
tient who cooperated in the study. An administrative
agreement was made between the Head of the Nephrology
Unit and Diabetic Center of King Fahad Hospital.
Socio-demographic, life style, and medical conditions data
were collected from the subjects using a pre-designed ques-
tionnaire and the Lab results were taken from the patients’
medical files. Socio-demographic data included several
criteria: age (20 to <40, 40 to <60 and 60e70 years of age),
sex (male or female), residence (urban or rural); marital status
(single, married, divorced or widowed), educational status
(illiterate, elementary, intermediate, high school, and univer-
sity or higher), occupation (unemployed, housewife, non-
skilled worker, skilled worker, employee, professional or
retired), and family history of diabetes mellitus and hyper-
tension (HTN) (1st relative, 2nd relative, or no family his-
tory). Life style factors included smoking (currently smoker,
never smoked, or ex-smoker); if smokers, patients were put
into three categories according to the duration of smoking in
years, the mean number of cigarettes per day (heavy, mod-
erate, or mild smoking) which are equal to 21, 11e20, and
1e10 cigarettes per day, respectively; patients’ body mass
index (BMI) was classified into four categories, underweight,
normal, overweight, and obese which equals <18.5, 18.5e
24.9, 25e29.9, and 30, respectively. The subjects’ medical
conditions included a medical history about the duration of
diabetes mellitus and hypertension; and associated HTN,
which was divided into four categories according to systolic
blood pressure, normotensive, mild, moderate, and severe
hypertension which equals 129, 130e150, 151e180, and
180 mmHg, respectively. There was a special reference to
related diseases (e.g., diabetic retinopathy, cardiac disease,
liver disease, and previous kidney disease) and to history of
significant drug usage such as angiotensin-converting-enzyme
inhibitor (ACEIs), Angiotensin II receptor blockers (ARBs)
and non-steroidalanti-inflammatory drugs (NSAIDs). The
Factors affecting albuminuria in diabetics252clinical and lab data were extracted from the subjects’ medical
files. These data included the degree of albuminuria (gm/
24 h), kidney function, liver enzymes, serum albumin, glyco-
sylatedhemoglobin (HbA1c) was and were grouped into three
categories, appropriate, fair, and poor which equals 6.5e
7.9%, 8e10%, and>10%, respectively; urine analysis, a
complete blood picture, abdominal ultrasound and fundo-
scopy were performed on every patient.Table 1: comparison between the studied diabetic patients with
and without diabetic nephropathy (DN) according to the Socio-Statistical analysis
The collected data were analyzed using the SPSS statis-
tical program (version 14). We compared diabetic nephrop-
athy and diabetic non-nephropathy by using the chi square
(c2) for the categorical variable and the t-test for continuous
variables. Univariate logistic regression analyses were used
to calculate the odds ratios (OR) and their 95% confidence
intervals (CI) for the association of diabetic nephropathy
with the socio-demographic, life style, diabetes mellitus-
related factors, and medical-associated factors. The missing
data in this study were treated by using the mean of the
corresponding variables in the whole study data (if contin-
uous). It is worth mentioning that only 1% of the data was
missing for three of the variables.
demographic characteristics.
Socio-demographic Patient with
DN (cases)
N ¼ 50
Patient without
DN (controls)
N ¼ 100
p-Value
No % No %
Age in group
20e<40 3 6.0 22 22.0 0.000*
40e<60 17 34.0 51 51.0
60e70 30 60.0 27 27.0
Sex
Male 35 70.0 49 49.0 0.015*
Female 15 30.0 51 51.0
Residence
Urban 48 88.0 88 88.0 0.112
Rural 2 12.0 12 12.0Results
Of the total 150 patients included in this study, the males
constituted 70% in the case study and 49% in the control
study. The females constituted 30% in the case study and
51% in the control study. The mean age of each participant
was 58.82  9.11 compared with 49.25  13.12 of controls
(Figure 1).
Table 1 shows a comparison of the socio-demographic
characteristics among cases and controls. From all socio-
demographic characteristics only age, sex, and occupation
showed statistically significant differences between cases and
controls (p ¼ 0.000, 0.015 and 0.007, respectively).
Regarding age, most cases were 60e70 years old (60%)Figure 1: Shows the distribution of age among cases and controls.compared to 27% of the controls. Regarding sex, the per-
centage of males was higher (70%) compared with controls
(49%). Regarding occupation most participants were retired
patients (60%) compared with 14% of the controls.
Table 2 shows a comparison of the lifestyle characteristics
among cases and controls and no significant differences were
noted between these two groups.
Table 3 shows a comparison between the DM-related
factors and medical-associated factors among cases and
controls. There were statistically significant differences be-
tween cases and controls with regards to diabetes duration,
control of diabetes, associated hypertension (HTN), and the
use of antihypertensive drugs (ACE inhibitors and ARBs)
(p ¼ 0.031, 0.01, 0.000 and 0.000, respectively). Nearly three
quarters (72%) of nephropathy patients (DN) had diabetes
for more than 10 years in comparison to 51% of non-
nephropathy patients (Figure 2). Nearly half (46%) of the
nephropathy patients had appropriate control over their
diabetes (6.5e7.9%) compared to 18% of controls. More
than half (54%) of the DN patients had mild hypertensionMarital status
Single 4 8.0 12 8.0 0.777
Married 43 86.0 81 86.0
Divorced 0 0 1 0.0
Widow 3 6.0 6 6.0
Education status
Illiterate 21 42.0 39 39.0 0.464
Elementary 7 14.0 22 22.0
Intermediate 3 6.0 4 4.0
High school 4 8.0 14 14.0
University
or more
15 30.0 21 21.0
Family history of DM
1st relative 35 70.0 63 63.0 0.687
2nd relative 4 8.0 9 9.0
No 11 22.0 28 28.0
Family history of HTN
1st relative 25 50.0 63 63.0 0.615
2nd relative 6 12.0 9 9.0
No 19 38.0 28 28.0
*Significant (p-value < 0.05).
Table 2: comparison between the studied diabetic patients with
and without diabetic nephropathy (DN) according to the
lifestyle.
Life style Patient with
DN (cases)
N ¼ 50
Patient without
DN (controls)
N ¼ 100
p-Value
NO % NO %
Smoking status
Yes 4 8.0 5 5.0 0.116
No 31 62.0 78 78.0
was 15 30.0 17 17.0
Type of smoking
Mild smoking 4 8.0 8 8.0 0.083
Moderate
smoking
5 10.0 6 6.0
Heavy smoking 9 18.0 6 6.0
Passive smoking
Yes 14 28.0 33 33.0 0.58
No 36 72.0 67 67.0
Duration of
smoking
20 6 12.0 16 16.0 0.628
>20 44 88.0 84 84.0
Body mass index
Underweight
(<18)
0 0 3 3.0 0.259
Normal
(18.5e24.9)
11 22.0 21 21.0
Overweight
(25e29.9)
14 28.0 39 39.0
Obese (30) 25 50.0 37 37.0
*Significant (p-value < 0.05).
Table 3: comparison between the studied diabetic patients with
and without diabetic nephropathy (DN) according to diabetic
mellitus (DM) related factors and medical associated factors.
Factors Patient with
DN (Cases)
N ¼ 50
Patient
without
DN (Controls)
N ¼ 100
p-Value
No % No %
Duration of DM in years
<5 3 6.0 18 18.0 0.031*
5e<10 11 22.0 31 31.0
>10 36 72.0 51 51.0
HbA1c (diabetic control)a
Appropriate 23 46.0 18 18.0 0.01*
Fair 16 32.0 51 51.0
Poor 11 22.0 31 31.0
Associated HTN
Normotensive 13 26.0 66 66.0 0.000*
Mild HTN 27 54.0 26 26.0
Moderate HTN 7 14.0 7 7.0
Severe HTN 3 6.0 1 1.0
Cardiac disease
Yes 17 66.0 12 12.0 0.002*
No 33 34.0 88 88.0
Using ACEIs and ARBs
ACE inhibitors 33 66.0 32 32.0 0.000*
ARBs 6 12.0 1 1.0
ACEIs and
ARBs
2 4.0 0 0.0
Not used 9 18.0 67 67.0
Associated retinopathy
Yes 27 54.0 36 36.0 0.053
No 23 46.0 64 64.0
Serum cholesterol
Normal 43 86.0 88 88.0 0.863
High 6 12.0 11 11.0
Low 1 2.0 1 1.0
Triglyceride
Normal 24 48.0 43 43.0 0.007*
High 21 42.0 25 25.0
Low 5 10.0 32 32.0
*Significant (p-value < 0.05).
a Diabetic control (6.5e7.9) appropriate control, (8e10) poor
control, (>10)very poor control.
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patients usedACEIs comparedwith 32%of controls. Cardiac
disease and triglyceride levels were significantly different
between cases and controls (p ¼ 0.02, and 0.007,
respectively). Two thirds (66%) of the DN patients had
cardiac diseases compared with 12% of controls. Nearly
half (42%) of the DN patients had retinopathy compared
with 15% of controls. Nearly half (48%) of the DN patients
had normal TG level compared with 43% of controls.
Table 4 shows the association between the socio-
demographic and lifestyle factors with diabetic nephropa-
thy in the diabetic patients. The age odds ratio (OR) was 8.1
(95% CI ¼ 2.2e30.1) for patients aged 60e70 years
compared with patients aged 20e40 years. The risk of
albuminuria was increased 2.4 times among male patients.
The risk of albuminuria was increased six times among
retired patients. The table also shows that smoking status
and BMI were not risk factors for DN.
Table 5 shows the association of diabetic nephropathy
according to factors that were statically significant by using
the OR and their 95% confidence interval (CI). The results
indicated that when the duration of DM was greater than 10
years there was a greater risk for albuminuria where the OR
were 4.23 (95% CI ¼ 1.6e15.4). The associated mild,
moderate, and severe hypertension increased the risk of
albuminuria where the ORs were 5.2 (95% CI ¼ 2.3e11.7),
5.1 (95% CI ¼ 1.5e16.9) and 15.2 (95% CI ¼ 1.4e158.1),respectively. These results indicate that patients with cardiac
disease had an increased risk of albuminuria where the ORs
were 3.77 (95% CI ¼ 1.6e8.7). We have also found that the
use of antihypertensive drugs (e.g., ACEIs and ARBs)
increases the risk of albuminuria where the OR was 8.1 (95%
CI ¼ 3.61e18.2). Alternatively, results have shown that
patients with low triglyceride levels had a reduced risk of
albuminuria with an OR of 0.38 (95% CI ¼ 0.10e0.81).Discussion
Diabetic nephropathy (DN) is the most frequent cause of
end stage renal disease.12 Albuminuria is considered as
Figure 2: Shows the distribution of duration of diabetes mellitus
among cases and controls.
Table 5: Odds ratio (OR) and 95% confidence interval (CI) for
the association of diabetes mellitus related factors and associ-
ated medical disorders with diabetic nephropathy in the studied
diabetic patients (Univariate analysis).
Factor Patients
with DN
(Cases)
N ¼ 50
Patients
without DN
(Controls)
N ¼ 100
OR 95% CI
Duration of diabetes
<5 years 3 18 1.00 Ref.
5e10 years 11 31 2.12 0.52e8.65
>10 years 36 51 4.23 1.61e15.4a
Associated hypertension
Normotensive 13 66 1.00 Ref.
Mild
hypertension
27 26 5.2 2.3e11.7a
Moderate 7 7 5.1 1.5e16.93a
Severe 3 1 15.2 1.4e158.1a
Associated heart diseases
No 33 88 1.00 Ref.
Yes 17 12 3.77 1.6e8.7a
Associated retinopathy
No 23 64 1.00 Ref
Yes 27 36 2.1 1.047e4.16
Using of antihypertensive drugs (ACEIs and ARBs)
No 10 67 1 Ref.
Yes 40 33 8.1 3.61e0.18.2a
Triglycerides level
Normal 24 43 1.00 Ref.
High 21 25 1.50 0.70e3.2
Low 5 32 0.38 0.10e0.81b
a Risk factor.
b Protective factor.
Factors affecting albuminuria in diabetics254the early predictor for advancement of diabetic
nephropathy.12Therefore, studying factors affecting
albuminuria should be considered a priority. In this study,
we have identified several factors which were significantly
associated with an increased risk of albuminuria in diabetic
patients. These factors include older age, sex (male),
retirement, duration of diabetes, hypertension (HTN),
cardiac disease and the use of antihypertensive drugs (e.g.,
ACE inhibitors and ARBs). On the other hand, we have
found that TG decreases the risk of the albuminuria in
diabetic patients.
It has previously been reported that older patients were at
an increased risk of DN.6,12 This has been confirmed in ourTable 4: Odds ratio (OR) and 95% confidence interval (CI) for
the association of socio-demographic and lifestyle factors with
diabetic nephropathy in the studied diabetic patients (Univari-
ate analysis).
Factor Patients with
DN (Cases)
N ¼ 50
Patients without
DN (Controls)
N ¼ 100
OR 95% CI
Age (years)
20e<40 3 22 1.00 Ref.
40e60 17 51 2.4 0.65e9.1
60e70 30 27 8.1 2.2e30.1a
Sex
Female 15 49 1.00 Ref.
Male 35 51 2.4 1.18e4.99a
Smoking status
Never 31 78 1.00 Ref.
Current
smoker
4 5 2.00 0.50e7.99
Ex-smoker 15 17 2.22 0.98e4.98
Body mass index (BMI)
<25 11 24 1.00 Ref.
25e<30 14 39 0.78 0.30e2.00
30 25 37 1.50 0.61e3.54
a Risk factor.study where we observed that the highest risk was among
those patients older than 60.
We have found that the frequency of diabetic nephropa-
thy was higher in male subjects than female subjects. This
observation has also been reported in previous studies.6,12
Many previous studies have shown that the duration of
diabetes was the most significant risk factor for developing
albuminuria in diabetic patients.6,12,13 These reported
observations are similar to our results.
We found that the HbA1c was better in the DN group
than in the control group. A possible explanation for this
finding could be that since this group was undergoing
treatment they might have been able to maintain stricter
control of their blood glucose levels for the past few months,
compared with the other group of non-nephropathy patients.
This may also suggest that the duration of diabetes could be a
more important risk factor in the progression of DN than
HbA1c, which stands in agreement with the study carried out
by Ahmedani et al.12
Several studies have shown an association between HTN
and the progression of albuminuria in diabetic patients,6,15,16
a result which has been confirmed in the current study.
In the present study, we have found no association be-
tween smoking and the progression of albuminuria in dia-
betic patients. This contrasts with the study conducted by
Kathy Nicholls,14 where subjects showed a positive
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nephropathy and its progression (i.e., an increase in
albumin excretion). This difference might be explained by
the fact that females in our sample constituted nearly half
of the study population and most of them had never smoked.
Contrary to previous reports regarding obesity,17,18 we
found no association between the progression of
albuminuria and obesity. A possible explanation for this
finding could be due to the exclusion of morbidly obese
patients from our current study.
Previous studies have documented a positive relationship
between cardiac disease and the progression of albuminuria
in diabetic patients.12,19 These reports are similar to the
findings in our current study. However, we found no
association between retinopathy and progression of
albuminuria in diabetic patients. The use of
antihypertensive drugs (ACE inhibitors and ARBs) has
been shown to increase the risk of albuminuria in diabetic
patients, which could be caused by glomerular injury as
described in the study done by Batlle et al.20
The significant impact of lower TG on the albuminuria in
our study agrees with the findings in previous studies21,22
showing renoprotective effects and decreased albuminuria
when treating high triglycerides in diabetic patients.
As far as we know, this study is the first of its kind to be
conducted here in Almadinah Almunawwarah. Studies per-
formed in the Kingdom of Saudi Arabia on the subject of
diabetic nephropathy are few.Study limitations
These study results cannot be generalized since they were
hospital-based in nature.
We did not adjust the observed risk (adjusted OR)
because of the small number of cases observed and the few
number of cases used during the performance of the analysis.Conclusion
In the present study, six factors showed a significant
positive relationship to the progression albuminuria in dia-
betic patients, which is consistent with most of the previously
reported studies. Analysis of the socio-demographic vari-
ables has shown that older age and males were found to be
predictors of high albuminuria. On the other hand, clinical
variables such as cardiac disease, poor HTN control and use
of ACEI or ARBs have been found to be predictors of higher
albuminuria. Furthermore, low triglyceride levels were
significantly associated with low albuminuria. Contrary to
other larger scale trials, higher levels of HBA1c have shown
less albuminuria while obesity (BMI), retinopathy and
smoking have shown no association to the albuminuria.Recommendations
We recommend that more studies be performed for
monitoring albuminuria and cardiovascular parameter in
patients in the Kingdom of Saudi Arabia. We also recom-
mend early monitoring of diabetic patients for albuminuria,
especially those with a long duration of diabetes.Author contributions
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